Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Times Interest Earned (2017 - 2018)

Cardiff Oncology's Times Interest Earned history spans 8 years, with the latest figure at -$17687.4 for Q4 2018.

  • For Q4 2018, Times Interest Earned changed N/A year-over-year to -$17687.4; the TTM value through Sep 2019 reached -$71089.2, down 10595.53%, while the annual FY2020 figure was -$9543.0, N/A changed from the prior year.
  • Times Interest Earned for Q4 2018 was -$17687.4 at Cardiff Oncology, up from -$240956.8 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$10.11 in Q3 2014 and bottomed at -$240956.8 in Q3 2018.
  • The 5-year median for Times Interest Earned is -$107.71 (2014), against an average of -$22022.5.
  • The largest annual shift saw Times Interest Earned surged 99.92% in 2014 before it crashed 154188.07% in 2018.
  • A 5-year view of Times Interest Earned shows it stood at -$10.11 in 2014, then tumbled by 79.8% to -$18.17 in 2015, then grew by 0.54% to -$18.07 in 2016, then tumbled by 764.14% to -$156.17 in 2017, then crashed by 11225.52% to -$17687.4 in 2018.
  • Per Business Quant, the three most recent readings for CRDF's Times Interest Earned are -$17687.4 (Q4 2018), -$240956.8 (Q3 2018), and -$4799.6 (Q2 2018).